Perception Regarding COVID 19 Vaccine And Survey Of Symptoms Following COVID-19 Vaccination In Hapur District Of Uttar Pradesh

Authors

  • Shazia Shafi G S Medical College Hospital, Uttar Pradesh, India https://orcid.org/0000-0003-0899-6095
  • Abhishek Mahajan G S Medical College Hospital, Uttar Pradesh, India.
  • Amal Titto V.Augustine MMMC&H, Solan, H.P, India.

DOI:

https://doi.org/10.37506/ctb0ex29

Keywords:

COVID 19 vaccine, perception, Post Covid 19 vaccination

Abstract

Background: COVID-19 vaccines have been rolled out recently in several parts of the world. Although the protective efficacy is frequently discussed, little is known about the real-world post-vaccination experience outside of clinical trial conditions. Knowledge about what to expect after vaccination will help educate the public, dispel misinformation and reduce vaccine hesitancy

 

Material & Methods: A cross-sectional study was conducted and all individuals who received COVID 19 vaccine at COVID 19 VACCINATION OPD at G S Medical college and Hospital at Hapur, Uttar Pradesh, after 20th may 2021 were included in the study.

 

Conclusion: It was observed that among the total participants majority (73.2%, 309) showed symptoms following COVID 19 vaccination. About (64.7%, 273) of the participants suffered from fever, (12.1%, 51) experienced joint pain followed by (9%, 38) chills and (5.7%, 24) myalgia. About (80.8%, 164) of study participants among the age group of 20-29 years followed by (81.6%, 62) of the study participants among the age group < 20 years observed post vaccination symptoms and this association was found to be statistically significant.

Author Biographies

  • Shazia Shafi, G S Medical College Hospital, Uttar Pradesh, India

    Assistant Professor

    Community Medicine

    G S MEDICAL COLLEGE & HOSPITAL, Hapur, Uttar Pradesh, India 

  • Abhishek Mahajan, G S Medical College Hospital, Uttar Pradesh, India.

    Associate Professor

    Community Medicine

    G S MEDICAL COLLEGE & Hospital, Hapur, Uttar Pradesh, India

  • Amal Titto V.Augustine, MMMC&H, Solan, H.P, India.

    Assistant Professor

    Community medicine

    MMMC&H, Solan, H.P.,India

References

WHO Coronavirus Disease (COVID-19) Dashboard [Internet]. [cited 2020 Dec 2]. Available from: https://covid19.who.int

Vellingiri B, Jayaramayya K, Iyer M, Narayanasamy A, Govindasamy V, Giridharan B, et al. COVID-19: A promising cure for the global panic. Sci Total Environ. 2020 Jul 10;725:138277.

Srikanth N, Gundeti MS, Rao B, Rai AK, Ahmad A, Negandhi H. Efficacy and Safety of Ayurveda Interventions as Standalone or Adjuvant Therapy in Management of COVID-19: A Systematic Review Protocol. J Res Ayurvedic Sci. 2020 Sep;4(3):121–7

Hajj Hussein I, Chams N, Chams S, El Sayegh S, Badran R, Raad M, et al. Vaccines Through Centuries:Major Cornerstones of Global Health. Front Public Health. 2015; 3:269. https://doi.org/10.3389/fpubh.2015.00269 PMID: 26636066; PubMed Central PMCID: PMC4659912.

Rodrigues CMC, Plotkin SA. Impact of Vaccines; Health, Economic and Social Perspectives. Front Microbiol. 2020; 11:1526. https://doi.org/10.3389/fmicb.2020.01526 PMID: 32760367; PubMed Central PMCID: PMC7371956.

Ehreth J. The value of vaccination: a global perspective. Vaccine. 2003; 21(27):4105–17. https://doi.org/10.1016/s0264-410x(03)00377-3 PMID: 14505886.

Wu F, Zhao S, Yu B, Chen Y-M, Wang W, Song Z-G, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579(7798):265–9. https://doi.org/10.1038/s41586-020- 2008-3 PMID: 32015508; PubMed Central PMCID: PMC7094943.

Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomedica. 2020; 91(1):157–60. Epub 2020/03/20. https://doi.org/10.23750/abm.v91i1.9397 PMID: 32191675; PubMed Central PMCID: PMC7569573.

Zimmer C, Corum J, Wee S-L. Coronavirus vaccine tracker US: The New York Times; 2020 [cited 2020 December 13]. Available from: https://www.nytimes.com/interactive/2020/science/coronavirusvaccine-

tracker.html.

Coustasse A, Kimble C, Maxik K. COVID-19 and Vaccine Hesitancy: A Challenge the United States Must Overcome. J Ambul Care Manage. 2021; 44(1). https://doi.org/10.1097/JAC.0000000000000360 PMID: 33165121.

Jayadevan R., Shenoy R., Anithadevi T. Survey of symptoms following COVID-19 vaccination in India. medRxiv. 2021 doi: 10.1101/2021.02.08.21251366.

Hervé, C., Laupèze, B., Del Giudice, G. et al. The how’s and what’s of vaccine reactogenicity. npj Vaccines 4, 39, 2019 https://doi.org/10.1038/s41541-019-0132-6

Post N et al, Antibody response to SARS-CoV-2 infection in humans: A systematic review PlosOne December 31, 2020 https://doi.org/10.1371/journal.pone.0244126

Christian LM, Porter K, Karlsson E, Schultz-Cherry S. Proinflammatory cytokine responses correspond with subjective side effects after influenza virus vaccination. Vaccine. 2015;33(29):3360-3366. doi:10.1016/j.vaccine.2015.05.008

Jennifer S. Chen, Mia Madel Alfajaro, Ryan D. Chow, Jin Wei, Renata B. Filler, Stephanie C. Eisenbarth, Craig B. Wilen. Non-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection. Journal of Virology Jan 2021, JVI.00014-21; doi: 10.1128/JVI.00014-21

Saleh E, Moody MA, Walter EB. Effect of antipyretic analgesics on immune responses to vaccination. Hum Vaccin Immunother. 2016;12(9):2391-2402. doi:10.1080/21645515.2016.1183077

Saied SM, Saied EM, Kabbash IA, Abdo SAE. Vaccine hesitancy: Beliefs and barriers associated with COVID-19 vaccination among Egyptian medical students. J Med Virol. 2021 Jul;93(7):4280-4291. doi: 10.1002/jmv.26910. Epub 2021 Mar 25. PMID: 33644891; PMCID: PMC8013865.

Mittal A, Jain B, Varshney AM, Garg G, Sachan D, Singh RB. Adverse effects after first and second dose of covishield and covaxin: A longitudinal study. J Family Med Prim Care. 2022 Nov;11(11):7339-7345. doi: 10.4103/jfmpc.jfmpc_885_22. Epub 2022 Dec 16. PMID: 36993127; PMCID: PMC10041308.

Hatmal MM, Al-Hatamleh MAI, Olaimat AN, Hatmal M, Alhaj-Qasem DM, Olaimat TM, Mohamud R. Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects. Vaccines (Basel). 2021 May 26;9(6):556. doi: 10.3390/vaccines9060556. PMID: 34073382; PMCID: PMC8229440.

El-Shitany N.A., Harakeh S., Badr-Eldin S.M., Bagher A.M., Eid B., Almukadi H., Alghamdi B.S., Alahmadi A.A., Hassan N.A., Sindi N. Minor to Moderate Side Effects of Pfizer-BioNTech COVID-19 Vaccine Among Saudi Residents: A Retrospective Cross-Sectional Study. Int. J. Gen. Med. 2021;14:1389–1401. doi: 10.2147/IJGM.S310497

Riad A., Pokorná A., Attia S., Klugarová J., Koščík M., Klugar M. Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic. J. Clin. Med. 2021;10:1428. doi: 10.3390/jcm10071428.

Kadali R.A.K., Janagama R., Peruru S., Gajula V., Madathala R.R., Chennaiahgari N., Malayala S.V. Adverse effects of COVID-19 mRNA-1273 vaccine: A randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms. J. Med. Virol. 2021 doi: 10.1002/jmv.26996.

Kadali R.A.K., Janagama R., Peruru S., Malayala S.V. Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers. Int. J. Infect. Dis. 2021;106:376–381. doi: 10.1016/j.ijid.2021.04.047

Menni C., Klaser K., May A., Polidori L., Capdevila J., Louca P., Sudre C.H., Nguyen L.H., Drew D.A., Merino J., et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: A prospective observational study. Lancet Infect. Dis. 2021 doi: 10.1016/S1473-3099(21)00224-3.

Chapin-Bardales J., Gee J., Myers T. Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines. JAMA. 2021 doi: 10.1001/jama.2021.5374

Downloads

Published

2024-09-20

How to Cite

Perception Regarding COVID 19 Vaccine And Survey Of Symptoms Following COVID-19 Vaccination In Hapur District Of Uttar Pradesh. (2024). Indian Journal of Public Health Research & Development, 15(4), 389-395. https://doi.org/10.37506/ctb0ex29